79.24MMarket Cap-2.08P/E (TTM)
0.550High0.510Low1.87MVolume0.520Open0.526Pre Close984.06KTurnover1.59%Turnover RatioLossP/E (Static)146.38MShares1.92052wk High2.97P/B63.80MFloat Cap0.49152wk Low--Dividend TTM117.87MShs Float24.570Historical High--Div YieldTTM7.54%Amplitude0.271Historical Low0.525Avg Price1Lot Size
Veru Inc Stock Forum
taking a position here earning this morning
The Phase 2b QUALITY study results represent a significant breakthrough in addressing a critical limitation of GLP-1 receptor agonists like Wegovy. The 71% reduction in lean mass loss and particularly the 99% preservation with the 3mg dose could position enobosarm as an essential companion therapy to GLP-1 drugs, especially for older adults where muscle preservation is crucial.
The body composition data is particularly compelling - while placebo + s...
Game-Changing Clinical Results: Veru's Drug Outperforms Weight Loss Giant Wegovy in Muscle Protection
Pain staking searches will always produce results. Patience is a virtue. Combining both makes for powerful decision-making.
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: La...
No comment yet